Universe Pharmaceuticals INC
UPC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001809616
No open-market purchases or sales by Universe Pharmaceuticals INC insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $228.4K in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Universe Pharmaceuticals INC changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 9 | 3 | −6 |
| Shares | 691.5K | 563.8K | −127.6K (−18.5%) |
| Value | $168.5K | $343.9K | +$175.4K (+104.1%) |
New holders (3)
Institutions that held Universe Pharmaceuticals INC at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 333,355 | $203.3K | 1.66% |
| Anson Funds Management LP | 230,407 | $140.5K | 0.02% |
| Morgan Stanley | 65 | $40 | 0.00% |
Sold out (9)
Institutions that held Universe Pharmaceuticals INC at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| UBS Group AG | 242,460 | $59.2K |
| MML Investors Services, LLC | 234,260 | $57.0K |
| Two Sigma Securities, LLC | 90,371 | $22.1K |
| Renaissance Technologies LLC | 39,267 | $9.58K |
| Quadrature Capital Ltd | 24,891 | $6.06K |
| Virtu Financial LLC | 16,585 | $4.00K |
| StoneX Group Inc. | 15,008 | $3.66K |
| XTX Topco Ltd | 14,820 | $3.62K |
| Millennium Management LLC | 13,809 | $3.37K |